Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2010
12/16/2010US20100316624 Treatment of fibroses and liver disorders
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316614 Compositions and methods for urinary bladder regeneration
12/16/2010US20100316589 Coated Pharmaceutical Compositions
12/16/2010CA2764782A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
12/16/2010CA2763537A1 Methods for treating chronic kidney disease
12/15/2010EP2261331A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis
12/15/2010EP2261250A1 Albumin fusion proteins
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260833A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
12/15/2010EP2259788A2 Treatment of bladder diseases with a tlr7 activator
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010CN101918364A Composition and method for treating proteinuria
12/15/2010CN101918021A Methods of treating urogenital-neurological disorders using modified clostridial toxins
12/15/2010CN101918012A Calcium-rich alkaline powder produced from processed molluse shells
12/15/2010CN101917998A Prevention of recurrence of urethral stricture after a conventional treatment
12/15/2010CN101917990A Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
12/15/2010CN101914536A Locked nucleic acid ribozyme of targeted serine-threonine protein kinase aurora kinase A and application thereof
12/15/2010CN101914426A Tortoise kidney tonifying wine
12/15/2010CN101912603A Compound of prostate stem cell antigen and heat shock protein and preparation method and application thereof
12/15/2010CN101912594A Traditional Chinese medicine preparation for treating gastrointestinal diseases
12/15/2010CN101912581A Chinese medicinal composition for treating cholecystitis and calculosis and preparation method thereof
12/15/2010CN101912565A Turmeric and astragalus capsules for treating diabetes and incipient diabetic nephropathy
12/15/2010CN101912559A Kidney-activating traditional Chinese medical pill capable of tonifying kidney, strengthening yang, maintaining beauty and treating infertility
12/15/2010CN101912518A Kidney-tonifying and yang-strengthening capsule
12/15/2010CN101912502A Traditional Chinese medicine for treating acute urethrocystitis
12/15/2010CN101912477A Health-care tea
12/15/2010CN101912448A Medicinal composition for treating benign prostatic hyperplasia, and preparation method and use thereof
12/15/2010CN101912402A Composition of cefazedone sodium sterile and clavulanate potassium and proportion thereof
12/15/2010CN101912398A Medicament for treating urinary tract infection
12/15/2010CN101912392A Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2010CN101912380A Compounds for the treatment of metabolic disorders
12/15/2010CN101912365A Sulbenicillin sodium powder injection and preparation process thereof
12/15/2010CN101461808B Fluorofenidone solid dispersoid and preparation thereof
12/15/2010CN101332178B Medicinal preparation for oral darifenacin or medicine salt thereof
12/15/2010CN101301347B Chinese medicine for treating impotence and preparation
12/15/2010CN101249170B Preparation of houttuynia cordata freeze-dried powder needle for injections
12/15/2010CN101234163B , preparation method of Chinese medicine composition for treating kidney deficiency and stasis resistance syndrome
12/15/2010CN101229194B Medicine for treating gall-stone, nephrolith and lithangiuria, preparing method thereof
12/15/2010CN101217960B Therapeutic agent and treatment method for ameliorating uremia
12/15/2010CN101138581B Traditional chinese medicine preparation for treating urinary system infection contamination and method of preparing the same
12/15/2010CN101006999B Therapeutic uses and compositions of isoflavones
12/14/2010US7851586 Peptides for activation and inhibition of δPKC
12/14/2010US7851507 Administering to a lung cancer patient 2-hydroxyoleic acid in an amount effective to inhabit proliferation of the cancer; leukemia, brain metastasis
12/14/2010US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
12/14/2010US7851444 χ-conotoxin peptides (-1)
12/14/2010US7851181 Generating monoclonal antibodies specific to insulin-like growth factor receptor-I (IGFR1) for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7850991 Calcium formate for use as a dietary supplement
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2446673C Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
12/14/2010CA2438339C Use of buprenorphine for treatment of urinary incontinence
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/09/2010WO2010140832A2 Pharmaceutical composition containing herbal extracts for preventing or treating nephritis
12/09/2010WO2010139482A1 Glomerulonephritis treatment
12/09/2010WO2010119294A3 Polyherbal animal feed composition
12/09/2010US20100313286 G protein-related kinase mutants in essential hypertension
12/09/2010US20100313285 Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation
12/09/2010US20100313283 Uses of gdnf and gdnf receptor
12/09/2010US20100313282 pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency
12/09/2010US20100311843 Compositions and methods for the treatment of glomerulonephritis
12/09/2010US20100311822 ACE2 Activation For Treatment Of Heart, Lung and Kidney Disease and Hypertension
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311799 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311775 Novel sEH Inhibitors and Their Use
12/09/2010US20100311772 Method and compounds for inhibition of cell death
12/09/2010US20100311768 Use of purine derivatives for the manufacture of a medicament
12/09/2010US20100311755 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
12/09/2010US20100311703 New compounds as adenosine a1 receptor antagonists
12/09/2010US20100311661 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
12/09/2010US20100311640 Self-assembling peptide incorporating modifications and methods of use thereof
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100310657 Pharmaceutical composition for treatment and prevention of kidney diseases
12/09/2010US20100310561 Natriuretic fusion proteins
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010CA2764465A1 Glomerulonephritis treatment
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258407A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/08/2010EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
12/08/2010EP2258360A2 Method for the treatment or prevention of lower urinary tract symptoms
12/08/2010EP2257296A1 Poly aromatic sodium channel blockers
12/08/2010EP2257294A2 Treatment of herpes virus related diseases
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP1082341B1 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/08/2010CN1907340B Quercetin content measuring method for renal stone removal preparation
12/08/2010CN101909609A Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
12/08/2010CN101906122A Method for extracting rhoifolin and prepared medicament application thereof
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
12/08/2010CN101906071A Dioxane-2-alkyl carbamates derivatives
12/08/2010CN101904991A Natural calculus-dissolving medicament
12/08/2010CN101904972A Traditional Chinese medicinal preparation for tonifying kidney and strengthening yang as well as benefiting sperm and nourishing development
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 562